1.52
-0.00999999(-0.65%)
Currency In USD
| Previous Close | 1.53 |
| Open | 1.53 |
| Day High | 1.56 |
| Day Low | 1.51 |
| 52-Week High | 22.8 |
| 52-Week Low | 1.45 |
| Volume | 88,964 |
| Average Volume | 366,584 |
| Market Cap | 4.99M |
| PE | -0.12 |
| EPS | -12.77 |
| Moving Average 50 Days | 1.71 |
| Moving Average 200 Days | 2.94 |
| Change | -0.01 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $24.72 as of December 25, 2025 at a share price of $1.52. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $2.87 as of December 25, 2025 at a share price of $1.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
GlobeNewswire Inc.
Dec 11, 2025 1:00 PM GMT
SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted how
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced today t
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
GlobeNewswire Inc.
Nov 06, 2025 1:00 PM GMT
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address key